Crossmark

Immunogenicity and efficacy of a Mycoplasma hyopneumoniae/porcine circovirus type 2 combination vaccine against experimental Mycoplasma hyopneumoniae infection in pigs

Crossref DOI link: https://doi.org/10.1186/s13567-026-01808-9

Published Online: 2026-07-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Li

Van Immerseel, Filip

Chantziaras, Ilias

Sonalio, Karina

Panneitz, Ana Karolina

Ma, Xiaoyan

Krejci, Roman

Maes, Dominiek

Devriendt, Bert
Funding

Funding for this research was provided by:

China Scholarship Council (202307550005)

China Scholarship Council (202407550008)

Ceva Santé Animale
License Information

Text and Data Mining valid from 2026-07-07

Version of Record valid from 2026-07-07
More Information

Article History

Received: 4 November 2025

Accepted: 15 June 2026

First Online: 7 July 2026

Declarations

:

: The study protocol was approved by the Ethical Committee of the Faculty of Veterinary Medicine and the Faculty of Bioscience Engineering, Ghent University (approval no. EC2024-023).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below